Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. - Wikidata - wikimedia - TriplyDB

Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation.

Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation.

http://www.wikidata.org/entity/Q30430659

about

A review of current status of living donor liver transplantation Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients Hepatocellular Carcinoma and Liver Transplantation: State of the Art Management of recurrent hepatocellular carcinoma after liver transplant Liver transplantation for hepatic tumors: a systematic review The Clinical Significance and Potential Therapeutic Role of GPx3 in Tumor Recurrence after Liver Transplantation.Liver transplantation for hepatocellular carcinoma from living-donor vs. deceased donor Long-term quality of life after liver donation in the adult to adult living donor liver transplantation cohort study (A2ALL).Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort.Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.Living Donor Liver Transplantation for Hepatocellular Carcinoma: It Is All about Donors?Hepatocellular carcinoma: early-stage management challenges Recent advances in liver transplantation for the practicing gastroenterologist Good longterm survival after primary living donor liver transplantation for solitary hepatocellular carcinomas up to 8 cm in diameter.Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation.Living-donor vs deceased-donor liver transplantation for patients with hepatocellular carcinoma.Hepatocellular carcinoma: review of current treatment with a focus on targeted molecular therapies.Scoring selection criteria including total tumour volume and pretransplant percentage of lymphocytes to predict recurrence of hepatocellular carcinoma after liver transplantation.Management of small hepatocellular carcinoma: a review of transplantation, resection, and ablation.The stratifying value of Hangzhou criteria in liver transplantation for hepatocellular carcinoma.Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation.Liver transplantation for hepatocellular carcinoma: outcomes and treatment options for recurrence.Incidence and risk factors of hepatocellular carcinoma recurrence after liver transplantation in the MELD era.Health-related quality of life of 256 recipients after liver transplantation The International Liver Transplantation Society Living Donor Liver Transplant Recipient Guideline.Living Donor Liver Transplantation Outcomes for Hepatocellular Carcinoma Beyond Milan or UCSF Criteria.Deceased-donor split-liver transplantation in adult recipients: is the learning curve over?Management of hepatocellular carcinoma: Enlightening the gray zones.Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome.Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.Live donors in liver transplantation.Liver transplantation for hepatocellular carcinoma: an appraisal of current controversies.Liver transplantation for small hepatocellular carcinoma.Liver transplantation for hepatocellular carcinoma: Korean experience.Liver transplantation for hepatocellular carcinoma: the Hong Kong experience.Living-donor or deceased-donor liver transplantation for hepatic carcinoma: a case-matched comparison.Does living donation have advantages over deceased donation in liver transplantation?Living donor liver transplantation: selection, perioperative care, and outcome.Should the liver transplant criteria for hepatocellular carcinoma be different for deceased donation and living donation?Role of organ transplantation in the treatment of malignancies: hepatocellular carcinoma as the most common tumour treated with transplantation.

P2860

Q26749857-120F2B2F-38DF-49B2-B37F-63901F69A624 Q26766049-6F21E92E-43C5-46AB-AA99-7E72A3519502 Q26781798-48AD7135-A687-4F07-8630-533BE375CC88 Q26997063-2978AA31-AFA6-4B93-A15C-1AD9794F5281 Q27021650-86EA3A6B-4E98-4523-8E82-6E9ED9A19208 Q27300764-FB6CD032-1EC6-4144-91FD-B25EB4DBE415 Q28073940-1ACE2F37-1EC8-44FA-BEBB-A39B0FAB0AD5 Q30361102-D7988FBE-AFD8-4689-AF80-869EFD3B39B1 Q30416480-9001871E-4229-4707-B5AD-B2D23B80CA77 Q30424714-5E4EAAEC-F4F4-4C66-92A1-91C198830B0B Q33872038-0CA2741D-A5E8-45B4-9E5F-DFF0A954BF91 Q33881131-C26EF460-7565-4978-BD4B-40606E45817E Q33916188-7E378142-7189-4F1A-9C74-5E6F0D4564A6 Q33960740-E4BCC2E5-7DC3-4794-82C7-84CD9E162B20 Q34067940-6AD83F29-47F6-4C26-92E2-AB0BFF28141C Q34263346-6D90BD1D-ECB8-4AAC-92A5-65FE34A44387 Q34409128-773447EC-D308-4A63-9598-C3002C90AB04 Q34977062-B677A810-DBBC-41CC-8116-44899A2C1658 Q35081063-D183FEC4-1745-480D-BFA2-7EE1F6287C75 Q35133600-7E63F5C7-3863-448C-B590-7C85EDA40940 Q35384660-3FBAD850-1F11-4218-924D-B10878CF7FB5 Q35779474-0A6AD194-E77F-42D2-B603-591110BBBED5 Q35785027-A92862E5-59FD-414D-8F67-5001C2523372 Q36285830-550B11B2-5857-44EB-85DA-CBAE79EEFD67 Q36355049-7C408D26-DD7D-4F86-99E6-5826FB8578AF Q36643551-C7BF4749-A106-42A8-81FB-E1EE6B10C15A Q36926615-BBF3525C-7DD5-4363-A1A2-722F664DAA44 Q36955647-1EC4C819-0F4C-499E-BC8E-5A1D2EDC0BA8 Q36962089-8C7BE807-0035-426F-AD5B-479349F1177C Q37068256-517BF4CC-8651-40AE-8A9E-E8F415EB99EB Q37124591-84FBF22F-7796-44E1-A1AE-189DB3E1F53A Q37140667-3A921C73-84ED-4F42-93A6-0CE033594053 Q37360177-A20143F2-6730-4357-B86B-32E8C6A71689 Q37591234-1EC53E7B-83E4-4953-BF07-A8EEC9E39010 Q37598591-C9107E38-3B2C-41E2-80BE-767CD14F5E08 Q37708048-A71B6343-D970-42F4-885B-AD24B606AFC1 Q37794228-7DC1F8B7-4B9D-467B-ABB7-D696A3573C8A Q37827248-8CC4D4D9-8F5F-444D-A364-363A8C3D7732 Q37883997-22F19A95-DCC4-497F-8FD2-CE15D265DE65 Q37928952-EAC337E1-E3BA-403F-8EA0-7A907A86665C

P2860

Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation.

http://www.wikidata.org/entity/Q30430659

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Hepatocellular carcinoma recur ...... d donor liver transplantation.

@ast

Hepatocellular carcinoma recur ...... d donor liver transplantation.

@en

type

label

Hepatocellular carcinoma recur ...... d donor liver transplantation.

@ast

Hepatocellular carcinoma recur ...... d donor liver transplantation.

@en

prefLabel

Hepatocellular carcinoma recur ...... d donor liver transplantation.

@ast

Hepatocellular carcinoma recur ...... d donor liver transplantation.

@en

P1433

Q30430659-33D396FF-422F-4C72-9816-FDDDEE56B971

P1476

Q30430659-18A697CB-22D8-442B-BEB1-D5F0A40261E1

P2093

Q30430659-06AEF145-0547-410D-AA62-5F362E2199FB

Q30430659-0E17A76C-E06F-41F8-B72B-08F364146272

Q30430659-2BCB1609-E323-44AE-AB24-CBF4D623DDA5

Q30430659-5C8B6CD2-D0E7-486B-802A-AA769EBA5AD9

Q30430659-87104E7F-CA75-4A80-B7F9-AFA11686BB7A

Q30430659-99C588DE-907A-4FC3-B2BA-6B20179CE2D1

Q30430659-9B7B62E5-2071-4543-ADDA-5E4215C4AEF6

Q30430659-AB083D87-A06F-4776-AB9F-843BB4191CC3

Q30430659-B6096976-9E35-4661-A971-6FE92385F9E1

Q30430659-BD486DAE-05EF-4345-8B8D-2C4246CF8FDD

P2860

Q30430659-07D85A43-CA3D-4AE3-8333-0F3E7192B0A3

Q30430659-085F91C9-18DC-41AC-959E-5944C8D9C81C

Q30430659-24B98401-C671-4B14-B57D-5F7C7B04DA9C

Q30430659-4E0D9948-0EB7-42C0-9497-386491B6D230

Q30430659-99B2618F-72B1-461D-9DCA-8FB664961C7B

Q30430659-C2BB7862-C721-41A0-8B99-BC3749064FFF

Q30430659-DF2F0A6A-75F0-4E26-B0E0-2B418EEC9CF1

Q30430659-E1DF0FB3-9F91-488B-8C5E-A6F060332CD8

Q30430659-F881BA34-6A90-4EE3-9F6F-EA0462BFCBA1

P304

Q30430659-16093887-7A32-4CF6-B104-40464E5367E6

P31

Q30430659-F51884F0-D830-4D7F-9363-00E0809F25D4

P356

Q30430659-1D0A1769-E315-4428-91F7-3E946C501CC7

P407

Q30430659-331CE0FC-43B6-4565-B70C-5661F9F358BF

P433

Q30430659-ADC778CD-130C-403E-AF34-5033794F2DD1

P478

Q30430659-84B80085-5F71-4376-A2A2-E79B55CA2D0A

P577

Q30430659-1FD746B2-1535-4999-AD28-69BBE3F216C2

P5875

Q30430659-495AE468-30B5-4585-B623-5B3561D14CAD

P698

Q30430659-F7E2C459-7AFF-4E3A-A003-8D2A6F9F4327

P921

Q30430659-705EAF41-AE8F-41A1-9580-F977999B25C7

P932

Q30430659-9EF06082-A5BC-46D9-A9AA-C630928F3639

P356

J.1600-6143.2007.01802.X

P1433

American Journal of Transplantation

P1476

Hepatocellular carcinoma recur ...... d donor liver transplantation.

@en

P2093

A S F Lok

http://www.w3.org/2001/XMLSchema#string

A2ALL Study Group

http://www.w3.org/2001/XMLSchema#string

C E Freise

http://www.w3.org/2001/XMLSchema#string

C L Berg

http://www.w3.org/2001/XMLSchema#string

I Kam

http://www.w3.org/2001/XMLSchema#string

J H Fair

http://www.w3.org/2001/XMLSchema#string

K M Olthoff

http://www.w3.org/2001/XMLSchema#string

L M Kulik

http://www.w3.org/2001/XMLSchema#string

R A Fisher

http://www.w3.org/2001/XMLSchema#string

R M Ghobrial

http://www.w3.org/2001/XMLSchema#string

P2860

Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

Improving liver allocation: MELD and PELD.

Living donor liver transplantation for hepatocellular carcinoma.

Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list.

Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list.

Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan.

A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.

Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective

P304

1601-1608

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1600-6143.2007.01802.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6320183

http://www.w3.org/2001/XMLSchema#string

P698

17511683

http://www.w3.org/2001/XMLSchema#string

P921

liver transplantation

P932

3176596

http://www.w3.org/2001/XMLSchema#string